Showing results (11-20 of 3,328) with videos related to
Sort By:
Pageof 333
The Oncologist|September 16, 2016
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate CancerEmmanuel S Antonarakis, Chandtip Chandhasin, Erica Osbourne, et al.The Prostate|July 13, 2016
Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or EnzalutamideMark C Markowski, Kevin D Frick, James R Eshleman, et al.Prostate Cancer and Prostatic Diseases|May 7, 2024
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trialMayuko Kanayama, Hua-Ling Tsai, Hao Wang, et al.Clinical Medicine Insights. Oncology|March 26, 2016
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate CancerKarim Boudadi, Emmanuel S AntonarakisCancer Chemotherapy and Pharmacology|March 10, 2010
Ruthenium-based chemotherapeutics: are they ready for prime time?Emmanuel S Antonarakis, Ashkan EmadiCancer Letters|April 24, 2012
Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastasesJatinder Goyal, Emmanuel S AntonarakisFuture Oncology (London, England)|June 26, 2019
Clinical implications of mismatch repair deficiency in prostate cancerRamy Sedhom, Emmanuel S AntonarakisClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2020
Reimagining Vaccines for Prostate Cancer: Back to the FutureEugene Shenderov, Emmanuel S AntonarakisCancer Management and Research|September 28, 2020
PARP Inhibitors in Metastatic Prostate Cancer: Evidence to DateEmily Nizialek, Emmanuel S AntonarakisClinical Medicine Insights. Urology|February 1, 2014
Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate CancerJatinder Goyal, Emmanuel S AntonarakisPageof 333